The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Onchocerciasis (River Blindness)

Filarial parasitic disease causing skin manifestations and blindness in endemic regions

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Internal Medicine department. Book Appointment →

What is Onchocerciasis (River Blindness)?

Onchocerciasis is a chronic parasitic disease caused by the filarial nematode Onchocerca volvulus, transmitted to humans via repeated bites of black flies (Simulium species) that breed in fast-flowing rivers, hence the term river blindness. It is the second leading infectious cause of blindness worldwide after trachoma, affecting approximately 21 million people globally with 99% in sub-Saharan Africa, particularly West and Central Africa, also endemic in Yemen and previously in Latin America (now eliminated through MDA programs).

Pathogenesis involves adult female worms (length 30-80 cm) and male worms (length 3-5 cm) residing in subcutaneous nodules (onchocercomas) where they live up to 15 years and produce millions of microfilariae that migrate through skin, eyes, and lymphatic system. Microfilariae cause inflammatory reactions when they die (often from drug treatment), releasing Wolbachia endosymbiotic bacteria that trigger pathology. Clinical features include onchodermatitis (severe pruritus, papular dermatitis, lichenification, leopard skin depigmentation, lizard skin atrophic changes), onchocercomas (subcutaneous nodules), lymphadenopathy with hanging groin, and ocular involvement (punctate keratitis, sclerosing keratitis, iridocyclitis, chorioretinitis, optic atrophy) progressing to blindness.

Diagnosis requires skin snip biopsy with microscopic examination for emerging microfilariae, slit-lamp examination of anterior chamber for ocular microfilariae, antibody serology (Ov-16), nodule excision histopathology, and PCR-based assays. Treatment is ivermectin 150 μg/kg orally as single dose every 6-12 months for 10-15 years (life span of adult worms), targeting microfilariae but not adult worms. Doxycycline 100 mg daily for 4-6 weeks targets Wolbachia endosymbionts and sterilizes adult worms. Mass drug administration (MDA) programs with annual ivermectin have reduced disease burden significantly. Surgical excision of accessible head and neck nodules complements pharmacotherapy.

Symptoms

Severe pruritus (intractable itching)
Papular dermatitis
Lichenification
Leopard skin depigmentation
Lizard skin atrophic changes
Subcutaneous nodules (onchocercomas)
Hanging groin (lymphadenopathy)
Lymphedema
Hypogonadism (in heavy infections)
Punctate keratitis (snowflake corneal opacities)
Sclerosing keratitis
Iridocyclitis (anterior uveitis)
Chorioretinitis
Optic neuritis
Optic atrophy
Visual field defects
Decreased visual acuity
Blindness (advanced disease)
Glaucoma (secondary to anterior segment inflammation)
Cataracts (complicating ocular inflammation)

Risk Factors

Residence in or travel to endemic areas (sub-Saharan Africa, Yemen)
Repeated black fly (Simulium) bites near fast-flowing rivers
Agricultural work near rivers
Outdoor occupations in endemic zones
Long duration of exposure (cumulative microfilarial load)
Lack of mass drug administration program coverage
Insecticide-resistant black fly populations
Climate change affecting vector distribution
Migration patterns introducing infection
Inadequate vector control measures
Limited access to ivermectin treatment
Coinfection with loa loa (Mazzotti reaction risk)
Severe anemia and malnutrition (worsening tolerance)
Pregnancy (complicates treatment options)
HIV coinfection
Immunosuppression
Children (heavy infection burden)
Lack of personal protective equipment (long sleeves, repellents)
Open water sources for bathing or washing
Poor housing without screens

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Severe pruritus in returning traveler from endemic area
  • Subcutaneous nodules with rural African residence
  • Eye symptoms with prior endemic exposure
  • Skin discoloration patterns
  • Visual changes in patient from endemic region
  • New-onset itching with travel history
  • Lymphadenopathy with skin changes
  • Considering preventive measures for travel
  • Mass drug administration program eligibility
  • Treatment of confirmed onchocerciasis
  • Suspected complications of treatment (Mazzotti reaction)
  • Long-term follow-up of treated patients
  • Loiasis screening before ivermectin
  • Co-management with HIV or other immunosuppression

Treatment Methods

01
Comprehensive evaluation by infectious disease specialist or tropical medicine expert
02
Detailed travel and exposure history including duration in endemic areas
03
Physical examination focused on skin, lymph nodes, eyes
04
Skin snip biopsy from multiple sites with microscopy for emerging microfilariae
05
Slit-lamp examination of anterior chamber for ocular microfilariae
06
Fundoscopy for retinal lesions and optic atrophy
07
Loiasis screening (Calabar swelling, blood film) before ivermectin in coendemic areas
08
Antibody serology (Ov-16 ELISA, rapid diagnostic test)
09
Nodule excision and histopathology when accessible
10
PCR-based diagnostic assays
11
Ophthalmologic consultation for complete eye assessment
12
Ivermectin 150 μg/kg orally as single dose, repeated every 6-12 months for 10-15 years
13
Mass drug administration (MDA) programs with community-directed treatment
14
Doxycycline 100 mg daily for 4-6 weeks targeting Wolbachia (sterilizes adult worms)
15
Combination of ivermectin and doxycycline for enhanced efficacy
16
Moxidectin (newer macrocyclic lactone, approved 2018) as alternative
17
Surgical excision of accessible head and neck nodules (nodulectomy)
18
Symptomatic management of skin lesions with antihistamines, topical steroids
19
Treatment of secondary bacterial skin infections
20
Ocular care for inflammatory complications
21
Cataract or glaucoma surgery as needed
22
Vector control with insecticide spraying of breeding sites
23
Personal protection (long sleeves, DEET-based repellents)
24
Avoidance of breeding sites near rivers
25
Mass drug administration coordination with local health authorities
26
Prophylaxis with ivermectin not currently recommended for travelers
27
Health education in endemic communities
28
Vector surveillance and control programs
29
Multidisciplinary care including dermatology, ophthalmology, infectious disease
30
Long-term follow-up for monitoring treatment efficacy

Which Department to Visit?

You can visit our Enfeksiyon Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Enfeksiyon Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Flu (Influenza)

Enfeksiyon Hastalıkları

Influenza is a seasonal contagious respiratory disease caused by influenza viruses; it presents with high fever, muscle pain, and severe fatigue.

COVID-19

Enfeksiyon Hastalıkları

COVID-19 is a contagious disease caused by the SARS-CoV-2 coronavirus with a wide clinical spectrum ranging from asymptomatic to severe pneumonia.

Upper Respiratory Tract Infection

Enfeksiyon Hastalıkları

Upper respiratory tract infections are diseases that include common cold, pharyngitis, sinusitis, and laryngitis, often of viral origin and self-limited.

Urinary Tract Infection

Enfeksiyon Hastalıkları

Urinary tract infections are common bacterial infections most often caused by Escherichia coli, presenting with burning and frequent urination.

Hepatitis A (HAV)

Enfeksiyon Hastalıkları

Hepatitis A is an acute, self-limited liver infection transmitted via the fecal-oral route causing acute hepatitis without chronicity; supportive care suffices in most cases, while vaccination prevents outbreaks and post-exposure prophylaxis within 2 weeks is effective.

Hepatitis B

Enfeksiyon Hastalıkları

Hepatitis B is a contagious infection caused by HBV virus transmitted via blood, sexual intercourse, and mother-to-child, that can become chronic and progress to cirrhosis and liver cancer.

Hepatitis C

Enfeksiyon Hastalıkları

Hepatitis C is a liver disease caused by HCV virus transmitted mainly by blood; the rate of chronicity is high, but cure is possible with new antiviral drugs.

HIV/AIDS Information

Enfeksiyon Hastalıkları

HIV is a virus that targets the immune system; if untreated, it progresses to AIDS. With modern antiretroviral therapy, HIV-positive individuals can lead healthy, long lives.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.